WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011

Vaccine

Volumn 30, Issue 45, 2012, Pages 6461-6471

  Klimov, Alexander I ^a   Garten, Rebecca ^a   Russell, Colin ^a,k   Barr, Ian G ^a,b   Besselaar, Terry G ^a,g   Daniels, Rod ^a,c   Engelhardt, Othmar G ^a,h   Grohmann, Gary ^a,j   Itamura, Shigeyuki ^a,d   Kelso, Anne ^a,b   McCauley, John ^a,c   Odagiri, Takato ^a,d   Smith, Derek ^a,k   Tashiro, Masato ^a,d   Xu, Xiyan ^a   Webby, Richard ^a,e   Wang, Dayan ^a,f   Ye, Zhiping ^a,i   Yuelong, Shu ^a,f   Zhang, Wenqing ^a,g   Cox, Nancy ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f Chinese National Influenza Center (CNIC)   (China)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

ⁱ CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^j THERAPEUTIC GOODS ADMINISTRATION   (Australia)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

Human; Influenza; Seasonal; Vaccine

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ANTIGENICITY; ARTICLE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; PHYLOGENETIC TREE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOUTHERN HEMISPHERE; VIRUS GENE; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

EID: 84866501152     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.089     Document Type: Article

References (13)

1. Barr I.G., McCauley J., Cox N., Daniels R., Engelhardt O.G., Fukuda K., et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2010, 28(February (5)):1156-1167.
2. World Health Organization Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Wkly Epidemiol Rec 2011, 86:81-92.
3. World Health Organization Recommended composition of influenza vaccines for use in the 2012 southern hemisphere influenza season. Wkly Epidemiol Rec 2011, 86:457-468.
4. World Health Organization. Standardization of terminology of the pandemic A(H1N1)2009 virus. Available from: http://www.who.int/influenza/gisrs_laboratory/terminology_ah1n1pdm09/en/.
5. Matrosovich M., Matrosovich T., Carr J., Roberts N.A., Klenk H.D. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol 2003, 77(August (15)):8418-8425.
6. WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva, 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf.
7. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003, 52(October (5)):696-704.
8. Posada D., Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14(9):817-818.
9. Zwickl DJ. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. Ph.D. Thesis; 2006.
10. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
11. Lin Y.P., Gregory V., Collins P., Kloess J., Wharton S., Cattle N., et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?. J Virol 2010, 84(July (13)):6769-6781.
12. Organization WH. Recommended composition of influenza virus vaccines for use in the 2012 southern hemisphere influenza season; 2011 [cited: 09/29/2011]. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2012south/en/index.html.
13. Rota P.A., Wallis T.R., Harmon M.W., Rota J.S., Kendal A.P., Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990, 175(March (1)):59-68.